News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
AstraZeneca PLC Plans to Delist Indian Arm, AstraZeneca Pharma India Ltd.
June 29, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SCRIP -- The board of AstraZeneca Pharma India has approved a proposal from its parent company, AstraZeneca Pharma AB, to delist the shares of the Indian arm from local bourses.
Twitter
LinkedIn
Facebook
Email
Print
Asia
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Job Trends
3 Top Challenges Facing Manufacturing Professionals Right Now
January 15, 2026
·
6 min read
·
Angela Gabriel
Alzheimer’s disease
Novartis Makes $1.5B+ Alzheimer’s Play With China’s SciNeuro
January 12, 2026
·
2 min read
·
Tristan Manalac
Policy
Flagship CEO Calls Out Attacks on Science, Warns of China Dominance
January 12, 2026
·
4 min read
·
Heather McKenzie
Lung cancer
Roche Spends $570M on Another ADC Agreement With China’s MediLink
January 9, 2026
·
1 min read
·
Tristan Manalac
